Skip to main content

Artal Group S.A.

SEC CIK
0001053906
Latest filing
Aug 13, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Artal Group S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2023
Holdings of MLTX by Artal Group S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−400,000−100.0%Sold outHolders
Q2 2023400,000$20.4M0.7%+400,000NewHolders